- Home
- DRUG vs PKBK Comparison
DRUG vs PKBK Comparison
Compare DRUG & PKBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- PKBK
- Stock Information
- Founded
- DRUG 2019
- PKBK 1999
- Country
- DRUG United States
- PKBK United States
- Employees
- DRUG N/A
- PKBK N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- PKBK Major Banks
- Sector
- DRUG Health Care
- PKBK Finance
- Exchange
- DRUG Nasdaq
- PKBK Nasdaq
- Market Cap
- DRUG 210.7M
- PKBK 249.7M
- IPO Year
- DRUG N/A
- PKBK N/A
- Fundamental
- Price
- DRUG $32.38
- PKBK $23.03
- Analyst Decision
- DRUG
- PKBK
- Analyst Count
- DRUG 0
- PKBK 0
- Target Price
- DRUG N/A
- PKBK N/A
- AVG Volume (30 Days)
- DRUG 382.4K
- PKBK 23.1K
- Earning Date
- DRUG 11-26-2024
- PKBK 10-18-2024
- Dividend Yield
- DRUG N/A
- PKBK 3.13%
- EPS Growth
- DRUG N/A
- PKBK N/A
- EPS
- DRUG N/A
- PKBK 2.33
- Revenue
- DRUG N/A
- PKBK $63,152,000.00
- Revenue This Year
- DRUG N/A
- PKBK N/A
- Revenue Next Year
- DRUG N/A
- PKBK N/A
- P/E Ratio
- DRUG N/A
- PKBK $9.80
- Revenue Growth
- DRUG N/A
- PKBK N/A
- 52 Week Low
- DRUG $0.93
- PKBK $15.24
- 52 Week High
- DRUG $79.02
- PKBK $23.44
- Technical
- Relative Strength Index (RSI)
- DRUG 43.69
- PKBK 65.53
- Support Level
- DRUG $36.02
- PKBK $22.25
- Resistance Level
- DRUG $44.70
- PKBK $23.10
- Average True Range (ATR)
- DRUG 5.79
- PKBK 0.54
- MACD
- DRUG -3.22
- PKBK 0.01
- Stochastic Oscillator
- DRUG 6.26
- PKBK 83.98
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.